UnitedHealth Group (NYSE:UNH) Issues FY20 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY20 earnings guidance on Monday morning. The company provided EPS guidance of $16.25-16.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.43. The company issued revenue guidance of $260-262 billion, compared to the consensus revenue estimate of $261.18 billion.UnitedHealth Group also updated its FY19 guidance to approach $15 EPS.

UnitedHealth Group stock traded down $0.21 during midday trading on Monday, hitting $279.66. The stock had a trading volume of 2,517,060 shares, compared to its average volume of 4,483,900. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market cap of $265.15 billion, a P/E ratio of 21.71, a P/E/G ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 12 month low of $208.07 and a 12 month high of $287.94. The business has a fifty day moving average price of $258.05 and a 200 day moving average price of $245.34.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. During the same period in the previous year, the firm posted $3.41 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group will post 14.96 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $1.08 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $4.32 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s payout ratio is currently 33.54%.

A number of equities analysts have commented on the company. Cantor Fitzgerald set a $310.00 target price on UnitedHealth Group and gave the company a buy rating in a research note on Tuesday, October 15th. Deutsche Bank assumed coverage on UnitedHealth Group in a research note on Thursday, September 12th. They issued a hold rating and a $263.00 target price for the company. Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the company a buy rating in a research note on Thursday, August 29th. Mizuho restated a buy rating and issued a $300.00 target price (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Finally, UBS Group decreased their target price on UnitedHealth Group from $281.00 to $257.00 and set a neutral rating for the company in a research note on Thursday, October 17th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. UnitedHealth Group has an average rating of Buy and an average price target of $289.39.

In other news, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the transaction, the chief accounting officer now directly owns 21,687 shares in the company, valued at $5,531,052.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Over the last quarter, insiders have sold 38,577 shares of company stock valued at $9,398,080. Insiders own 0.82% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Resistance Level

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.